Power Corp of Canada’s Bristol-Myers Squibb BMY Stock Holding History

Power Corp of Canada’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,671	Closed	-$2.97M	–	71
2022 Q1	$2.97M	Buy	+40,671	New	+$2.73M	0.25%	55

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Power Corp of Canada's BMY Position: Q2 2022 in Review

Power Corp of Canada sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 40,671 shares — an estimated $2.97M sold.

Power Corp of Canada first reported a position in BMY in Q1 2022 and held it in 1 quarter. The position peaked at $2.97M in Q1 2022. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Power Corp of Canada reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Power Corp of Canada sold 40,671 Bristol-Myers Squibb shares in Q2 2022, an estimated $2.97M.
Power Corp of Canada first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 1 quarter.
Power Corp of Canada's Bristol-Myers Squibb position peaked at $2.97M in Q1 2022.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Power Corp of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.